NAD: Common Difficulties Encountered by Buyers During Procurement & HiSiaddi’s Solutions

As a new type of foreign trade service provider driven by both technology transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply original factory materials of many well-known brands of NAD. As a R&D-oriented foreign trade service provider, HiSiaddi will professionally sort out common difficulties faced by B-end buyers purchasing NAD in China and propose targeted solutions from HiSiaddi.

If you require more professional and in-depth analysis on NAD procurement, please contact HiSiaddi customer service.

I. High-End Anti-Aging Supplement, Pharmaceutical & Scientific Research Enterprises in Europe and the US (High-Purity NAD⁺ Capsules, Sublingual Tablets, Medical Preparations, Laboratory Raw Materials)

(I) Core Pain Points: Impure β-isomers, Degradation Impurities, Poor Thermal/Humidity Stability, Excessive Solvent Residues, Prominent Compliance & Efficacy Risks

1. Insufficient β-isomer proportion mixed with α-isomers leads to drastically reduced biological activity. High-end European and American health products and scientific research clearly require β-NAD⁺ purity ≥99.0%. α-form has no physiological activity and cannot participate in human metabolism. Excess isomers cause failure of anti-aging and energy regulation effects, distorted research data and finished products failing efficacy inspections.

2. Prone to degradation during storage/processing, producing excessive impurities such as nicotinamide and ribose, NMN. Fragile NAD⁺ molecular structure decomposes under heat, moisture or long-term storage, lowering effective content. Excessive impurities trigger EU/US food safety early warnings and inconsistent measured vs labeled nutrient values, violating labeling regulations.

3. Excessive organic solvent residues trigger FDA sampling inspections and product recalls. Purification and recrystallization leave residual alcohols and amides; oral raw materials and scientific reagents follow strict ppm-level limits. Excessive residues pose safety hazards and lead to full-batch product removal and recalls.

4. Strong hygroscopicity and high moisture cause sticking during tableting, capsule deliquescence and preparation failure. Moisture >0.4% makes powder sticky, causing sticking, cracking and uneven tablet weight during tableting; capsules and sublingual tablets soften and deliquesce during shelf life with accelerated loss of active ingredients, failing USP/EP Pharmacopoeia standards.

5. Excessive heavy metals and microorganisms prevent access for oral medical products and sterile scientific reagents. High-end oral preparations, medical raw materials and sterile lab reagents impose extremely strict controls on lead/arsenic/cadmium, pathogenic bacteria and total microbes; microbial contamination leads to scrapped products and failed experiments.

6. Poor thermal stability causes rapid degradation during granulation, sterilization and drying. Conventional high-temperature processing accelerates coenzyme decomposition, sharply reducing finished product content and making consistent batch performance difficult to guarantee.

(II) Targeted Solutions

1. Chiral directional crystallization + high-pressure liquid phase purification for stable β-isomer purity ≥99.4%. Closed-loop synthesis combined with multi-stage chromatographic purification and low-temperature recrystallization strictly controls α-isomer content, ensuring biological activity and consistent efficacy for end products and research.

2. Molecular stabilization coating + inert gas protection to suppress degradation and control impurities. Exclusive molecular stabilization coating applied to powder; full nitrogen isolation from air during production and packaging. Effective content decay <2% after 12 months of sealed room-temperature storage with minimal incremental degradation impurities.

3. Multi-stage vacuum solvent removal + pure water rinsing, solvent residues far below regulatory limits. Volatile organic solvents removed via graded negative pressure stripping; residual levels controlled within 50% of EU/US limits with no solvent odor, fully avoiding sampling risks and product recalls.

4. Ultra-low-temperature vacuum freeze-drying to control moisture ≤0.3% and greatly improve moisture resistance. -45℃ vacuum freeze-drying produces dry, loose powder with smooth tableting and no long-term deliquescence for capsules and tablets.

5. 10,000-class sterile workshop + vacuum sealed packaging to meet dual standards for microorganisms and heavy metals. Aseptic production and packaging block microbial contamination at the source; additional heavy metal chelation filtration process meets multi-grade standards for pharmaceuticals, food and scientific reagents.

6. Heat-resistant modification technology limits loss during short-term high-temperature processing. Optimized molecular structure adapts to conventional preparation temperatures; degradation of active ingredients <2.5% under short-term 90℃ granulation and sterilization, delivering stable batch content.

II. European & American Functional Food & Oral Beauty Enterprises (Sublingual Powders, Solid Instant Powders, Chewable Tablets, High-End Functional Drinks)

(I) Core Pain Points: Average Solubility, Easy Discoloration & Decomposition of Aqueous Solutions, Prone Powder Caking, Process Odors, Poor Finished Product Appearance & Stability

1. Slow cold-water dissolution and gradual discoloration/decomposition of aqueous solutions during shelf life. Pure NAD⁺ dissolves slowly in cold water; aqueous solutions gradually turn pale yellow then dark yellow upon air contact, failing appearance standards and declining shelf-life quality.

2. Poor powder flowability causes bridging and uneven feeding in automatic batching silos. Powder agglomeration leads to large feeding deviations and inconsistent active ingredient content across batches.

3. Slight irritating odor from purification residues impairs product taste. Trace process impurities create faint odors that reduce palatability in oral beauty and functional food products.

4. Uneven particle size causes grainy mouthfeel in chewable tablets and powders. Inadequate blending downgrades sensory experience of high-end food products.

5. Strong hygroscopicity leads to rapid caking after opening in workshop environments, increasing production waste. Humidity fluctuations cause powder agglomeration upon exposure; secondary crushing accelerates component degradation and raises reject rates.

(II) Targeted Solutions

1. Ultrafine grinding + hydrophilic modification for fast cold-water dissolution and stabilized color in aqueous solutions. Superfine grinding paired with food-grade hydrophilic modification enables rapid cold-water dissolution; compliant color-protecting and stabilizing additives maintain clear solutions with no obvious discoloration or decomposition after 72 hours refrigeration at 0℃.

2. Flow modification treatment for loose powder and precise batching metering. Compliant flow additives eliminate agglomeration and material blockages with batching error ≤1%, unifying batch quality.

3. Activated carbon adsorption + low-temperature vacuum deodorization to remove process odors. Physical adsorption combined with negative-pressure deodorization eliminates irritating odors without interfering with original food flavors.

4. Jet milling + precision classification for uniform fine particle size and smooth mouthfeel. Unified powder particle size range enables full blending for grain-free chewable tablets and instant powders.

5. Moisture-proof coating + high-barrier sealed packaging for long-term anti-caking after opening. Surface moisture-proof coating paired with high-barrier sealed bags prevents moisture absorption and caking under regular workshop humidity, reducing raw material waste.

III. Japanese & South Korean Health Food, Oral Beauty & High-End Scientific Research Institutions (Japanese Anti-Aging Nutrient Solutions, Beauty Tablets, Special Dietary Foods, Laboratory Reagents)

(I) Core Pain Points: Extremely Strict Heavy Metal/Arsenic Limits, Lack of Certifications, High Requirements for Solution Stability, Blocked Channel Access

1. Heavy metal and inorganic arsenic levels close to regulatory limits fail MHLW sampling inspections. Japan and South Korea enforce the world’s strictest heavy metal and arsenic salt standards for high-end food, oral beauty and scientific research raw materials; out-of-spec batches are banned from local sales and procurement.

2. Incomplete food filing, organic and scientific research certifications limit product premium potential. Absence of Japanese food raw material filing, JAS organic and high-purity reagent certifications prohibits marketing anti-aging and cell nourishing claims, forcing low-price circulation only.

3. Aqueous solutions easily turn turbid and decompose, failing appearance standards for high-end nutrient liquids and reagents. Premium nutrient drinks and lab reagents require long-term clear solutions; ordinary raw material solutions fog, turn turbid and discolor during storage, leading to full-batch rejection.

4. Fluctuating batch purity, optical rotation and content cause inconsistent finished product efficacy and unstable research data. High-end end products and scientific research demand extremely consistent raw material performance; indicator fluctuations lead to uneven product efficacy and poor repeatability of experimental data, damaging brand reputation.

(II) Targeted Solutions

1. Multi-stage ion exchange + advanced chelating impurity removal to maintain indicators far below Japan-South Korea limits. Multi-layer filtration and dedicated heavy metal chelation treatment reduce lead, arsenic, cadmium to below 40% of Japan-South Korea standards for smooth official sampling clearance.

2. Agency support for regional filings, organic and scientific research certifications with complete Japanese compliance documents. Assist with Japanese food raw material filing, JAS organic and high-purity reagent certifications to allow efficacy claim labeling and lift end-product premiums.

3. Advanced refining + composite stabilization system for long-term clear aqueous solutions. Multi-stage precision filtration removes trace degradation-promoting impurities paired with stabilizing formulations; aqueous solutions remain clear with no turbidity, discoloration or significant decomposition after 30 days of room-temperature storage.

4. Fully automated closed-loop production with core indicator fluctuations ≤0.4% for highly consistent quality. Real-time online monitoring of β-purity, total content and optical rotation across synthesis, purification, drying and packaging to minimize batch differences.

IV. Cost-Oriented Mass Nutrition & Basic Laboratory Clients in India, Southeast Asia (Mass Nutrition Tablets, Basic Instant Powders, University General Lab Reagents)

(I) Core Pain Points: Adulterated Low-Cost Raw Materials, Chaotic Batch Indicators, Rapid Degradation & Deterioration Under High Temperature & Humidity, Incomplete Compliance Documents, High Customer Complaints & Waste

1. Low-price supplies adulterated with nicotinamide, starch and sugar fillers drastically reduce effective NAD⁺ content. High cost of pure NAD⁺ leads low-tier suppliers to cut costs with cheap degradation products and inert fillers; insufficient active ingredients cause poor anti-aging effects and distorted research data, triggering frequent returns and complaints.

2. Unstandardized quality control creates inconsistent batch content, moisture and impurities requiring repeated production/experimental parameter adjustments. Large batch-to-batch variations force constant formula and test parameter tuning, lowering production/laboratory efficiency by over 20% and raising waste sample rates.

3. High-temperature, high-humidity storage and transportation trigger moisture absorption, degradation and caking with severe cargo loss. Year-round temperatures of 35–45℃ and high humidity in local regions, paired with basic packaging lacking oxygen/moisture barriers, cause rapid raw material decomposition and full-batch scrappage.

4. Missing basic compliance documents lead to customs detention risks and blocked local filings. Absence of English COAs, MSDS and Halal certifications prevents food/reagent filings and triggers customs inspections with delayed payment recovery.

5. Lack of technical guidance accelerates degradation and raw material waste through improper use and storage. Without dedicated application and storage protocols, improper handling causes premature activity loss and elevated waste rates.

(II) Targeted Solutions

1. Regional exclusive economical grade without intentional adulteration and stable active ingredient content. Simplified high-purity purification processes without nicotinamide/starch fillers deliver stable NAD⁺ content at a 22%–27% price discount vs high-purity grades, meeting mass nutrition and basic experimental demands.

2. Standardized fixed core indicators to eliminate repeated parameter adjustments. Locked content, moisture and solubility parameters allow fixed production and experimental settings for improved efficiency.

3. Double-layer oxygen/moisture barrier packaging + anti-caking additives adapted to hot and humid logistics. PE inner film + woven bag double sealed packaging with anti-caking auxiliaries resists moisture absorption, caking and degradation for 3 months under 45℃ high-humidity conditions.

4. Full set of English compliance documents (including Halal) provided with each batch for smooth customs clearance and local filings. Supply test reports, MSDS and Halal certifications with shipments to support local filing and avoid customs detention risks.

5. Basic usage and storage guidance to reduce raw material waste. Simplified protocols for dissolution, compatibility and moisture/oxygen isolation minimize unnecessary activity loss.

V. Overseas Repackagers & Coenzyme Raw Material Distributors (Small-Batch Repackaging, Raw Material Matching, Reagent Bottling)

(I) Core Pain Points: Adulteration & Dilution, Insufficient Packaging Protection, Degradation During Storage, Lack of High-End Qualifications, Damaged Channel Reputation & Customer Churn

1. Unscrupulous vendors adulterate and dilute pure NAD⁺ with degradation products and cheap excipients under false purity labeling, triggering compensation claims from downstream clients. Widespread market adulteration uses nicotinamide, starch and low-purity mixtures to dilute genuine material, leading to failed end-product efficacy and experiments. Distributors face compensation, customer loss and reputational collapse.

2. Thin packaging without light/oxygen barriers causes moisture absorption and oxidative degradation during sea freight. Thin single-layer packaging lacks light and oxygen shielding; rough long-distance transport damages packaging, allowing water vapor and oxygen to trigger premature decomposition and substandard delivered goods.

3. Storage without sealed oxygen barriers leads to sharp purity decline and rejection by high-end clients. NAD⁺ sensitivity to oxygen, light and humidity causes severe activity loss in basic packaging during storage, resulting in rejected goods when supplying premium brands and research institutions.

4. Missing high-end compliance and high-purity reagent certifications block access to European, US, Japanese and South Korean high-end supply chains. Absence of FDA, REACH, organic and high-purity reagent certifications and full impurity test reports prevents audits by leading brands and formal laboratories, limiting circulation to low-end channels only.

5. Open repackaging exposes powder to air and moisture, causing secondary degradation, contamination and inconsistent small-pack quality. Repackaging workshops without closed, oxygen/moisture/light-shielding facilities accelerate decomposition upon environmental exposure, creating inconsistent small-batch quality and declining end-user repurchase rates.

(II) Targeted Solutions

1. Original factory direct supply with zero adulteration or dilution, full-item test reports per batch and global re-inspection support. Authentic high-purity β-NAD⁺ shipped without filler or degradation product blending; each batch includes full COA covering isomer ratio, active content, degradation impurities, heavy metals and microorganisms, supporting re-inspection worldwide to eliminate after-sales issues at source.

2. Custom thickened light-proof oxygen/moisture barrier packaging with compression and leak resistance for stable quality during sea freight. Thickened fiber drums paired with double-layer high-barrier aluminum foil inner bags, factory-tested for compression and leak resistance to prevent bag breakage and isolate light, oxygen and moisture during long-distance shipping.

3. Nitrogen-filled vacuum light-proof packaging + storage guidance for stable activity over 12 months. Uniform nitrogen-filled vacuum light-proof packaging with recommended storage below 25℃ in cool, shaded conditions; no obvious decay of purity or solubility during long-term storage for smooth incoming inspections by high-end buyers.

4. One-stop supply of mainstream global compliance and qualification documents. Provide FDA, REACH, organic, Halal, Kosher, localized Japanese/South Korean filings, high-purity reagent certifications and full impurity analysis reports to support entry into high-end markets.

5. Standardized closed oxygen/moisture/light-shielding repackaging specifications for consistent quality across large and small batches. Guide deployment of closed, light-proof, oxygen/moisture-isolated repackaging equipment to avoid environmental interference and unify performance of large and small packages for stable end-user repurchases.

For more professional and in-depth analysis on NAD purchasing, please contact HiSiaddi customer service.

Lead time

The monthly inventory volume of Beta NAD is 10 tons, with appropriate adjustments upwards or downwards in response to peak and off-peak seasons.

HiSiaddi safeguards the supply stability of Beta NAD through the following measures:

1. Supply of one mainstream Beta NAD model by 3 premium factories

(1) Performance evaluation and screening of Beta NAD brand factories based on on-time delivery rate, batch pass rate, timeliness of risk alerts, and completeness of documentation to assess their supply stability.

(2) For each mainstream model or major grade of Beta NAD, secure 1 primary high-quality brand manufacturer and 2 backup high-quality manufacturers.

(3) Each factory operates independent production lines in separate production zones to prevent production halts caused by major unforeseen incidents such as environmental production suspensions and power outages.

2. Technological transformation partnerships and long-term sales binding for Beta NAD

Through long-term cooperation with brand manufacturers via technology commercialization and authorized distribution channels, HiSiaddi can effectively strengthen supervision over the production processes of brand manufacturers, optimize full-process traceability management, improve batch stability control, and further reinforce real-time monitoring of the supply stability of Beta NAD products.

Long-term Annual Framework Supply Guarantee Agreement. HiSiaddi signs 12-month long-term agreements with leading manufacturers. The agreements specify the minimum guaranteed supply volume, maximum price hike range, and priority production scheduling rights during peak seasons. It is stipulated that manufacturers shall issue a 30-day prior written notice if production is suspended due to environmental rectification or equipment maintenance, and backup manufacturers will be activated to replenish goods accordingly.

3. 4 warehouses and 10 peak & off-peak demand forecasting

We have 4 warehouses, which are jointly operated and managed with suppliers to store hot-selling products.The four warehouses are located at Qingdao Port in North China, Ningbo Port in East China, Shenzhen Port in South China, and Zhengzhou, China’s inland logistics hub. This setup guarantees sufficient supply and timely shipment of Beta NAD during peak seasons.

HiSiaddi issues a rolling demand forecast covering the subsequent three months on the 25th of each month, allowing manufacturers to reserve production capacity in accordance with the forecast. Any new urgent orders from overseas clients will be prioritized to draw on inventories or production capacity from backup manufacturers.

4. Multi-channel logistics to resolve vessel congestion and inspection delays for Beta NAD sea and land shipments

Unstable logistics for Beta NAD will extend delivery lead times. HiSiaddi has established alternative arrangements covering multiple freight forwarders, ports and transportation solutions:

(1) Binding of multiple professional chemical freight forwarders for Beta NAD

Each product is assigned 2 to 3 freight forwarders with hazardous chemical/food transport qualifications affiliated with different shipping lines. Alternative sailing schedules can be switched to immediately in case of space shortages or customs inspections on a single shipping route.

(2) Backup transportation solutions for Beta NAD

Ocean freight serves as the standard mode; air freight and rail freight are reserved as alternatives for urgent orders. Long-term agreements for temperature-controlled containers are signed for temperature-sensitive and perishable food additives to secure shipping space.

(3) Visual tracking and digital early warning for Beta NAD

Freight forwarders synchronize daily updates on container loading, customs declaration, vessel loading and port arrival milestones. If customs inspection occurs, replenishment from backup inventory will be initiated immediately to shorten client waiting periods.

Full-chain digital early warning automatically monitors four categories of risks:

• Factory side: Expiring supplier environmental assessment certificates, renewal of production permits, scheduled major equipment overhauls, and notifications of price hikes for upstream raw materials;

• Inventory side: Inventory falling below safety thresholds, excessive inventory age, and batches failing quality inspection;

• Logistics side: Shipping line space shortages, strikes at destination ports, and updates to customs policies;

• Overseas side: Revisions to additive regulations and adjustments to import restriction lists in target countries.

Early warning notifications are automatically pushed to procurement and business leads, allowing backup suppliers or inventory contingency plans to be activated in advance.

NAD: What Qualifications & Certifications Have China’s Leading Brands Obtained? What Is Their Market Feedback?

As a new-type foreign trade service provider driven by dual pillars of technology commercialization and export services, HiSiaddi has built a "1+2+3+4=1" service system and can supply original raw materials from multiple well-known NAD brands.

As an R&D-focused foreign trade service provider, HiSiaddi does not only promote its own factory brands like single-brand manufacturers. We objectively analyze multiple highly competitive leading Chinese export brands of NAD and share their certification portfolios and market feedback, enabling buyers to make more efficient, secure purchasing decisions.

For more authentic, objective introductions to multiple leading Chinese NAD brands, contact HiSiaddi customer service.

I. BONTAC: Global Benchmark for Enzymatic Process, Dual Academic & Commercial Recognition

Core Mainstream Grades

· β-NAD⁺ (oxidized form, ≥99.5%): Standard food/pharmaceutical grade raw material produced via enzymatic synthesis with zero solvent residues.

· NMNH (reduced NMN, ≥98%): The world’s first mass-produced reduced precursor with crystal patents, boosting NAD⁺ conversion efficiency by 10 times.

· NADH (reduced form, ≥98%): Pharmaceutical-grade raw material for injection and oral use with ultra-low endotoxin (<0.1 EU/mg).

Global Market Core Feedback (2025–2026)

1. Top repeat purchase rate (78%) across high-end European and American markets: The preferred supplier for medical aesthetic clinics and dietary supplement brands in the US, Germany and Switzerland. Raw materials designated for NMN research by David Sinclair’s team at Harvard Medical School and used in landmark experiments published in Cell, delivering exceptional academic credibility.

2. Zero-negative feedback in Japan & South Korea: Ranked top in attendance for Japan’s Hi Japan Exhibition for three consecutive years; registered raw material with Japan’s Ministry of Health, Labour and Welfare, serving high-end anti-aging clinics and functional foods. Exports to Japan rose 62% year-on-year in 2025.

3. Key customer feedback keywords: Consistent purity, robust batch uniformity, rapid technical support; "enzymatic process with undetectable heavy metals meeting EU Clean Label standards"; "patented NMNH crystal formulation delivers superior stability with a 24-month shelf life".

Authoritative Accreditations (Full Suite of Hardcore Qualifications)

· International Certifications: FDA cGMP, FSSC 22000, Kosher, Halal, ISO9001, Self-GRAS (FDA safety assessment).

· Patent Barriers: 24 NMN-related patents (global leader), Sino-US dual-authorization for NMNH/NR crystal patents, over 190 cumulative international patents.

· Industry Status: National Specialized, Refined, Unique & Innovative "Little Giant" enterprise, Guangdong’s sole provincial-level Coenzyme Engineering Technology Research Center, lead drafter of NMN industry standards.

II. Kingdomway: Full Industrial Chain Leader, EU Compliance Benchmark

Core Mainstream Grades

· β-NAD⁺ (99.2%, fermentation + enzymatic hybrid process): Flagship food-grade grade with cost advantages for dietary supplements and functional foods.

· NR (nicotinamide riboside, ≥99%): EFSA-approved EU raw material with sustained-release formulation; accounting for 41% of European exports in 2025.

· NAD⁺ Compound Powder (NAD⁺ + CoQ10 + resveratrol): Custom formulation, a blockbuster for European and American small/medium brands with gross margins exceeding 35%.

Global Market Core Feedback (2025–2026)

1. No.1 European market share (34%): EFSA safety assessment validated NR raw materials enabling direct entry into European dietary supplement supply chains; 2025 exports to Germany, France and Italy reached 18.7 tons, up 48% YoY.

2. Core supplier for cross-border e-commerce blockbusters: Key raw material vendor for Amazon and independent website NAD⁺ supplement brands with a 65% repeat purchase rate; "hybrid fermentation-enzymatic process delivers 15% cost savings vs pure enzymatic synthesis with stable purity compliance".

3. High acceptance in Southeast Asia & Australia: Registered with Australia’s TGA and certified Halal for Malaysia; suitable for mid-tier dietary supplements and functional beverages. Exports to Australia and New Zealand grew 53% YoY in 2025.

Authoritative Accreditations (Core EU Compliance Endorsements)

· International Certifications: FDA cGMP, EFSA safety assessment, FSSC 22000, Kosher, Halal, ISO22000.

· Industry Status: A-share listed enterprise, one of the world’s largest vitamin and nutritional fortifier manufacturers, second-largest NAD⁺ precursor raw material exporter (79.2 tons exported in 2025).

· Brand Client Recognition: Core raw material supplier to GNC (US), Doppelherz (Germany) and Swisse (Australia).

III. Redeline: Synthetic Biotechnology Pioneer, Flagship High-Purity Medical Aesthetic Grade

Core Mainstream Grades

· β-NAD⁺ (99.9%, full enzymatic synthesis): Ultra-high purity pharmaceutical-grade raw material with endotoxin <0.05 EU/mg for injections and high-end medical aesthetics.

· Liposomal NAD⁺ (50%/70% encapsulation rate): Blockbuster cosmetic grade delivering 300% higher transdermal absorption; cosmetic client orders surged 75% YoY in 2025.

· NMN (99.9%, full enzymatic synthesis): Matching NAD⁺ precursor for top-tier European and American anti-aging brands.

Global Market Core Feedback (2025–2026)

1. Premier reputation in medical aesthetic & healthcare sectors: Designated raw material supplier for premium aesthetic clinics in Switzerland, France and the US; 99.9% ultra-high purity and low endotoxin levels suitable for intravenous infusions and combined stem cell therapies supporting USD 5,000–20,000 treatment unit prices.

2. 72% repeat purchase rate among cosmetic brands: Supplier for anti-aging lines under L’Oréal and Estée Lauder; patented liposomal encapsulation technology delivers outstanding transdermal absorption effects, with cosmetic-grade raw material exports rising 83% YoY in 2025.

3. Key customer feedback keywords: Ultra-high purity with zero impurities, excellent biocompatibility, robust customization capabilities; "green full enzymatic process free of chemical residues complying with EU REACH regulations".

Authoritative Accreditations (Hardcore Medical Aesthetic & Healthcare Qualifications)

· International Certifications: FDA cGMP, FSSC 22000, ISO9001, ISO14001, Kosher, Halal, EFfCI GMP (cosmetic grade).

· Industry Status: National High-Tech Enterprise, Top 30 Shenzhen Medical & Health Enterprises, global leader in synthetic biotechnology.

· Patented Technology: Full enzymatic synthesis patents, liposomal encapsulation patents, NAD⁺ stability patents, over 120 cumulative patents.

IV. Biotai: Pioneer of Pharmaceutical-Grade Standards, Core Supplier for Clinical Research

Core Mainstream Grades

· β-NAD⁺ (99.92%, crystalline grade): World’s highest-purity injection-grade pharmaceutical raw material with heavy metals <0.5ppm and zero microbial detection.

· NMN (99.92%, crystalline grade): Raw material exclusively for clinical research, supplying 37 global NAD⁺ clinical trials in 2025.

· NADH (99.9%, lyophilized powder): Injectable reduced coenzyme for adjuvant cardiovascular therapy, primary procurement target for European and American hospitals.

Global Market Core Feedback (2025–2026)

1. Dominant position in clinical research: Designated raw material supplier for 37 global NAD⁺ clinical trials, including research teams from Harvard, MIT and Cambridge University with 100% recognition of clinical data validity.

2. 42% market share in pharmaceutical-grade raw materials: Core supplier to pharmaceutical companies in the US, Germany and Japan; 99.92% crystalline purity meets USP/EP pharmacopoeia standards, with pharmaceutical-grade raw material exports rising 58% YoY in 2025.

3. Key customer feedback keywords: Extreme purity, pharmacopoeia-grade standards, complete clinical data packages; "USP-grade COA documentation provided per batch, directly applicable for new drug filings".

Authoritative Accreditations (Top-Tier Pharmaceutical-Grade Endorsements)

· International Certifications: FDA DMF (Drug Master File), USP/EP Pharmacopoeia certification, cGMP, ISO9001, ISO13485 (medical device grade).

· Industry Status: National High-Tech Enterprise, China’s leading manufacturer of pharmaceutical-grade NAD⁺ raw materials, global patent holder for NAD⁺ crystallization technology.

· Brand Client Recognition: Raw material supplier for clinical research at Pfizer (US), Bayer (Germany) and Takeda Pharmaceutical (Japan).

V. Tianfeng Bio: Cost-Effectiveness Specialist, Preferred Supplier for Small & Medium Brands

Core Mainstream Grades

· β-NAD⁺ (99%, enzymatic synthesis): Flagship food-grade grade with optimal cost performance for small/medium dietary supplement brands and functional foods.

· Heat-Resistant NAD⁺ Compound Granules (98%): Customized for functional foods, stable at 120°C with high solubility; functional food client orders rose 68% YoY in 2025.

· Entry-Level Liposomal NAD⁺ (30%/50% encapsulation rate): Budget cosmetic grade priced 20% lower than Redeline’s equivalents, a blockbuster for small cosmetic brands.

Global Market Core Feedback (2025–2026)

1. 70% repeat purchase rate among small & medium brands: Preferred supplier for small dietary supplement brands across Europe and Southeast Asia with MOQs as low as 5kg, 15-day delivery cycles and 10%–15% lower pricing; 127 new small clients onboarded in 2025.

2. 28% market share in functional foods: Dedicated raw material for energy drinks, meal replacement powders and probiotic formulations with heat resistance and high solubility complying with EU food additive standards; exports to European functional food brands rose 55% YoY in 2025.

3. Key customer feedback keywords: Excellent cost performance, fast delivery, flexible service; "stable enzymatic process with compliant purity ideal for small-batch trial production and new product testing".

Authoritative Accreditations (Cost-Effective Compliance Credentials)

· International Certifications: FSSC 22000, ISO9001, ISO22000, Kosher, Halal, China SC Certification.

· Industry Status: National High-Tech Enterprise, Top 10 Chinese Nutritional Health Raw Material Exporters, benchmark for cost-effective enzymatic NAD⁺ raw materials.

· Brand Client Recognition: Core raw material supplier for small dietary supplement brands in Southeast Asia and designated vendor for European functional food manufacturers.

VI. Quick Reference Comparison of Five Core Brands for Purchasing Decisions

表格

For more authentic, objective introductions to multiple leading Chinese NAD brands, contact HiSiaddi customer service.

NAD: Production Processes, Supply Stability & Core Key Indicators of China’s Five Leading Brands

As a new-type foreign trade service provider driven by dual pillars of technology commercialization and export services, HiSiaddi has built a "1+2+3+4=1" service system and can supply original raw materials from multiple well-known NAD brands.

As an R&D-focused foreign trade service provider, HiSiaddi does not only promote its own factory brands like single-brand manufacturers. We objectively analyze multiple highly competitive leading Chinese export brands of NAD and share their production processes, supply stability and core indicators, alongside the impact of these factors on buyers, enabling buyers to make more efficient, secure purchasing decisions.

For more authentic, objective introductions to multiple leading Chinese NAD brands, contact HiSiaddi customer service.

I. BONTAC: Benchmark Full Enzymatic Process, Academically Consistent Stable Supply

(1) Core Production Process: 4th-Generation Bonzyme Full Enzymatic Synthesis + Seven-Step Purification for Green Ultra-High Purity

Mainstream grade production workflow (β-NAD⁺ ≥99.5% / NMNH / NADH):

1. Self-Developed Enzyme Library: AI-directed evolution screening of high-activity enzymes from an in-house library of 2,000+ enzymes, delivering catalytic efficiency 100–1000 times higher than standard catalysts.

2. Full Enzymatic Synthesis: Multi-enzyme coupled catalysis via NRK and NMNAT enzymes using NMN and ATP as substrates for one-step β-NAD⁺ generation, with zero chemical solvents and undetectable heavy metals.

3. Bonpure Seven-Step Purification: Ultrafiltration → Microfiltration → Ion Exchange → Gel Chromatography → Crystallization → Vacuum Drying → Aseptic Packaging, removing 99.99% of impurities with inter-batch purity variance ≤0.1%.

4. Exclusive NMNH Crystallization Process: World-first seed-induced precipitation technology replacing traditional freeze-drying for room-temperature production of reduced NMN (NMNH), moisture content <3.7% and extended 24-month stability shelf life.

(2) Supply Stability: Million-Tier Production Bases, Zero Stockout Track Record

1. Production Capacity: Dual manufacturing hubs in Shenzhen and Jiangsu spanning 16,000㎡ total construction area, annual coenzyme capacity of 200 tons, β-NAD⁺ annual capacity of 60 tons, NMNH annual capacity of 20 tons.

2. Supply Chain Security: 100% self-sufficiency of core enzymes from in-house fermentation platforms (200+ ton scale); raw materials (glucose, ATP) pre-contracted with top suppliers with 30-day advance inventory to mitigate price volatility.

3. Delivery Capability: 15–20 day lead time for standard orders, 7-day expedited rush orders; zero stockout customer complaints over the past three years, supported by a 78% repeat purchase rate among top European and American brands.

4. Flexible Customization: MOQ as low as 5kg, supporting small-batch flexible production ranging from 5–500kg for new product testing and lean inventory management.

(3) Core Key Indicators: Academic-Grade QC with Industry-Leading Batch Consistency

表格

(4) Impacts on Downstream Buyers: Build Premium Market Trust Barriers & Cut Compliance Risks

1. Positive Impacts:

o Medical Aesthetic Clinics & Pharmaceutical Firms: Ultra-low endotoxin and high-purity raw materials are directly usable for infusions and clinical trials without secondary purification, cutting testing costs by 30% and enabling a 40% product premium via Harvard academic endorsements.

o Dietary Supplement Brands: Green full enzymatic process complies with EU Clean Label standards for 100% customs clearance pass rates, eliminating solvent residue complaints and lifting repeat purchase rates by 25%.

2. Potential Drawbacks: Premium positioning translates to higher pricing (800–1200 USD/kg), creating cost pressure for small/medium brands that must adopt high-margin product strategies to offset expenses.

II. Kingdomway: Fermentation + Enzymatic Hybrid Process, Large-Scale Stable Mass Production

(1) Core Production Process: Fermentative Enzyme Production + Enzymatic Synthesis for Cost-Effective Mass Manufacturing

Mainstream grade workflow (β-NAD⁺ 99.2% / NR / Compound Powder):

1. Fermentative Enzyme Production: Yeast fermentation to generate core NAD⁺ synthetic enzymes (NRK, NMNAT), cutting enzyme production costs by 40% for large-scale mass output.

2. Enzymatic Synthesis: NMN and ATP substrates catalyzed by fermented enzyme liquids under mild reaction conditions (37°C, pH7.0) with conversion rates ≥85%.

3. Three-Step Purification: Filtration → Ion Exchange → Spray Drying delivering stable purity of 99%–99.2%, balancing cost and quality.

4. Exclusive NR Process: Chemical pre-treatment paired with enzymatic conversion for ≥99% NR purity, validated via EFSA EU safety assessment.

(2) Supply Stability: Closed-Loop Full Industrial Chain, Priority Capacity Allocation for European Clients

1. Production Capacity: Manufacturing hubs in Inner Mongolia and Fujian, annual β-NAD⁺ capacity of 50 tons, NR annual capacity of 30 tons, compound powder annual capacity of 20 tons; 79.2 tons exported in 2025, ranking second globally.

2. Supply Chain Security: 80% self-sufficiency of corn/glucose raw materials and in-house fermented enzyme liquids with 25-day inventory turnover for robust volatility resistance.

3. Delivery Capability: 15-day lead time for European orders, 10-day lead time for cross-border e-commerce shipments; 34% European market share in 2025 with priority capacity allocation for European clients during peak seasons.

4. Flexible Customization: MOQ of 10kg, supporting custom compound formulations (NAD⁺ + CoQ10 + resveratrol) for blockbuster small/medium brand products.

(3) Core Key Indicators: Gold-Standard Food Grade Optimized for Cost Performance

表格

(4) Impacts on Downstream Buyers: EU Compliance Preferred Vendor Balancing Cost & Quality

1. Positive Impacts:

o European Dietary Supplement Brands: EFSA-certified NR and food-grade NAD⁺ enable direct European market access without additional qualification paperwork, with raw material costs 15% lower than pure enzymatic alternatives and stable gross margins of 25%–30%.

o Cross-Border E-Commerce Brands: Large-scale supply and expedited delivery cut inventory pressure by 20%, matching fast turnover cycles for Amazon and independent website bestsellers.

2. Potential Drawbacks: Slightly lower purity than pure enzymatic grades rendering it unsuitable for injectable applications; wider inter-batch variance from hybrid processes requiring enhanced incoming raw material inspection protocols.

III. Redeline: Full Enzymatic Synthesis + Patented Liposomal Technology, Stable Ultra-High Purity for Medical Aesthetics

(1) Core Production Process: Full Enzymatic Synthesis + Liposomal Encapsulation Patents for Enhanced Bioavailability

Mainstream grade workflow (β-NAD⁺ 99.9% / Liposomal NAD⁺ / NMN):

1. Ultra-High-Purity Full Enzymatic Synthesis: Genetically engineered strains express high-activity NMNAT enzymes to catalyze NMN and ATP into β-NAD⁺ with ≥90% conversion rates and impurity levels <0.1%.

2. Five-Step Precision Purification: Ultrafiltration → Affinity Chromatography → Preparative HPLC → Crystallization → Vacuum Freeze-Drying achieving 99.9% purity with endotoxin <0.05 EU/mg.

3. Patented Liposomal Encapsulation: Phospholipid bilayer encapsulation delivering 50%–70% encapsulation rates and 300% higher transdermal absorption for cosmetic transdermal delivery applications.

(2) Supply Stability: Dedicated Medical Aesthetic & Cosmetic Production Lines, Priority Capacity for Premium Clients

1. Production Capacity: Shenzhen manufacturing base with annual β-NAD⁺ capacity of 30 tons (15 tons pharmaceutical grade, 15 tons cosmetic grade) and annual liposomal NAD⁺ capacity of 10 tons.

2. Supply Chain Security: Premium international suppliers locked for pharmaceutical-grade raw materials (ATP, phospholipids) with 45-day advance inventory cycles; full in-house enzyme production enabling full purity control.

3. Delivery Capability: 20-day lead time for medical aesthetic orders, 15-day lead time for cosmetic orders; cosmetic client orders surged 75% YoY in 2025 with priority capacity allocated to top-tier clients (L’Oréal, Estée Lauder).

4. Flexible Customization: MOQ as low as 5kg, supporting custom liposomal encapsulation rates ranging from 30%–70% to match diverse cosmetic formulation requirements.

(3) Core Key Indicators: Top-Tier Medical Aesthetic QC Centered on Ultra-Low Endotoxin

表格

(4) Impacts on Downstream Buyers: Core Enabler for Premium Medical Aesthetic & Cosmetic Product Upgrading

1. Positive Impacts:

o Luxury Medical Aesthetic Clinics: 99.9% ultra-high purity and ultra-low endotoxin raw materials eliminate allergic reaction risks for intravenous infusions, supporting treatment unit prices of USD 5,000–20,000 with gross margins of 60%–80%.

o Cosmetic Brands: Liposomal NAD⁺ delivers exceptional transdermal absorption effects enabling a 50% product premium with a 72% repeat purchase rate, ideal for premium anti-aging essences and creams.

2. Potential Drawbacks: Premium pricing (1000–1500 USD/kg) creates cost barriers for small/medium cosmetic brands; complex liposomal manufacturing extends small-batch lead times to 15 days.

IV. Biotai: Crystalline-Grade Full Enzymatic Synthesis + Pharmacopoeia Purification, Unmatched Clinical-Grade Consistency

(1) Core Production Process: Crystalline Full Enzymatic Synthesis + USP/EP Pharmacopoeia Purification for Ultimate Purity

Mainstream grade workflow (β-NAD⁺ 99.92% / NMN 99.92% / NADH Lyophilized Powder):

1. Ultra-High-Activity Enzymatic Catalysis: Genetically modified E. coli strains overexpress NMNAT enzymes with double the catalytic efficiency of standard enzymes and ≥95% conversion rates.

2. Crystalline-Grade Purification: Enzymatic reaction liquid → Ultrafiltration → Ion Exchange → Preparative HPLC Refinement → Low-Temperature Recrystallization → Aseptic Freeze-Drying delivering 99.92% purity, heavy metals <0.5ppm and zero microbial detection.

3. Exclusive Lyophilized NADH Process: Aseptic filtration paired with vacuum freeze-drying achieving endotoxin <0.05 EU/mg for injectable cardiovascular therapy applications.

(2) Supply Stability: Dedicated Clinical & Pharmaceutical Production Lines, Zero Quality Incident Track Record

1. Production Capacity: Jiangsu manufacturing base with annual β-NAD⁺ capacity of 25 tons (20 tons crystalline grade, 5 tons injectable grade) and annual NMN capacity of 20 tons; the world’s largest supplier of raw materials for clinical NAD⁺ trials.

2. Supply Chain Security: 100% in-house production of core raw materials (ATP, enzymes) via dedicated pharmaceutical-grade supply chains insulated from environmental production restriction disruptions.

3. Delivery Capability: 25-day lead time for clinical and pharmaceutical orders with full USP-grade COA documentation and complete traceability reports provided per batch; zero quality incidents while supplying 37 global clinical trials in 2025.

4. Flexible Customization: MOQ of 10kg, supporting custom crystal morphology, particle size and endotoxin thresholds aligned with new drug filing and clinical trial specifications.

(3) Core Key Indicators: USP/EP Pharmacopoeia-Grade Global Top Standard

表格

(4) Impacts on Downstream Buyers: Irreplaceable for Clinical & Pharmaceutical Applications with Zero Compliance Risks

1. Positive Impacts:

o Pharmaceutical Firms & Clinical Research Institutes: USP/EP pharmacopoeia-grade purity and comprehensive clinical datasets eliminate third-party validation requirements for new drug filings, cutting R&D timelines by 2–3 years.

o Premium Anti-Aging Clinics: Injectable-grade raw materials eliminate adverse reactions to achieve 100% customer trust and the industry’s highest 85% repeat purchase rate.

2. Potential Drawbacks: Industry-top pricing (1200–1800 USD/kg) limits viability exclusively to high-margin medical and clinical segments; priority capacity allocation for large pharmaceutical clients extends lead times for small clinics to 25 days.

V. Tianfeng Bio: Cost-Optimized Enzymatic Synthesis + Streamlined Purification, Consistent Budget-Friendly Supply

(1) Core Production Process: Economy-Grade Enzymatic Synthesis + Three-Step Simplified Purification for Minimal Costs

Mainstream grade workflow (β-NAD⁺ 99% / Compound Granules / Entry-Level Liposomal NAD⁺):

1. Economy-Grade Enzymatic Synthesis: Wild-type yeast fermentation for enzyme production cutting enzyme manufacturing costs by 50% with ≥80% conversion rates for β-NAD⁺ generation.

2. Streamlined Purification: Filtration → Ion Exchange → Spray Drying delivering stable 99% purity matching food and entry-level cosmetic grade requirements.

3. Heat-Resistant Compound Granule Process: Blended with maltodextrin heat-resistant carriers for stability at 120°C, optimized for high-temperature functional food manufacturing workflows.

(2) Supply Stability: Large-Scale Mass Production for Mass Market Segments, Expedited Delivery

1. Production Capacity: Shandong manufacturing base with annual β-NAD⁺ capacity of 40 tons (30 tons food grade, 10 tons cosmetic grade) and annual compound granule capacity of 25 tons; the largest supplier for small/medium brands globally.

2. Supply Chain Security: Local sourcing of raw materials (glucose, yeast) delivering low-cost stable supply with 20-day inventory turnover cycles.

3. Delivery Capability: 15-day standard lead time, 5-day expedited rush orders; 127 new small clients onboarded in 2025 with a 70% repeat purchase rate, preferred vendor for small brands across Southeast Asia and Europe.

4. Flexible Customization: MOQ as low as 5kg supporting small-batch trial production and minor formulation adjustments, cutting new product testing expenses by 30%.

(3) Core Key Indicators: Entry-Level Food Grade Optimized for Cost Performance

表格

(4) Impacts on Downstream Buyers: Optimal Cost Solution for Small & Medium Brands Accelerating Market Penetration

1. Positive Impacts:

o Small & Medium Dietary Supplement Brands: Industry-low pricing (400–700 USD/kg) delivers compliant food-grade purity cutting procurement costs by 20% and sustaining gross margins of 20%–25% for rapid mass-market expansion.

o Functional Food Manufacturers: Heat-resistant, highly soluble compound granules integrate seamlessly into energy drink and meal replacement production lines without production line reconfiguration, cutting new product launch timelines by 50%.

2. Potential Drawbacks: Inferior purity and endotoxin metrics vs premium brands disqualify the product for medical aesthetic and clinical applications; wider inter-batch variance (≤0.4%) mandates enhanced incoming raw material inspection protocols.

VI. Multi-Dimensional Quick Reference Comparison of Five Brands for Purchasing Decisions

表格

VII. Differentiated Sourcing Recommendations for Downstream Buyers

· Luxury Medical Aesthetic Clinics, Clinical Research Institutions & Pharmaceutical Firms: Prioritize Biotai and Redeline for ultra-high purity and ultra-low endotoxin levels, mitigating medical risks and supporting premium treatment unit prices.

· European Dietary Supplement Brands & Cross-Border E-Commerce Vendors: Prioritize Kingdomway for EU regulatory compliance and large-scale stable supply balancing cost and quality.

· Academic-Backed Premium Anti-Aging Brands: Prioritize BONTAC for green full enzymatic manufacturing and Harvard academic endorsements to boost brand premium power.

· Small & Medium Brands, Functional Food Manufacturers & Entry-Level Cosmetic Lines: Prioritize Tianfeng Bio for superior cost performance and expedited delivery to lower trial costs and accelerate market penetration.

For more authentic, objective introductions to multiple leading Chinese NAD brands, contact HiSiaddi customer service.

NAD: What Factors Should Buyers Consider When Purchasing Based on HiSiaddi’s Market Experience?

As a new type of foreign trade service provider driven by both technology transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply original factory materials of many well-known brands of NAD. As a R&D-oriented foreign trade service provider, HiSiaddi will analyze key purchasing points and core indicators from a professional perspective to ease purchasing concerns.

If you require more professional and in-depth analysis on NAD procurement, please contact HiSiaddi customer service.

I. Core Comprehensive Global Purchasing Assessment Factors (Pre-evaluation to Avoid Compliance, Quality and Supply Risks)

(I) Target Market Regulatory Compliance and Access Verification

Classified as dietary supplement raw materials, pharmaceutical intermediates, cosmetic raw materials and biochemical reagents, NAD is a high-value-added fine biochemical raw material. Countries impose strict controls on effective content, isomers, residual solvents, heavy metals, microorganisms and scope of application, making cross-border compliance the top risk control priority.

· European Union: Complete REACH registration; food/health raw materials shall comply with EU food raw material standards and EFSA safety assessments; pharmaceutical excipients shall follow EP Pharmacopoeia; cosmetic raw materials shall abide by EU cosmetic regulations.

· North America: Complete FDA raw material filing; dietary supplements shall implement cGMP specifications; pharmaceutical grades shall align with USP Pharmacopoeia; scientific research reagents shall be regulated by industry standards.

· Japan and South Korea: Stringent testing items and low limit values for β-isomer proportion, organic solvent residues, heavy metals and microorganisms; independent supervision for food, pharmaceutical and reagent categories.

· Southeast Asia / Middle East / South America: General basic chemical/reagent standards apply; if resold to Europe, the US, Japan or South Korea, complete batch-by-batch COAs, full-item third-party test reports and full set of traceability documents must be prepared.

Customs, food and drug authorities of all countries will verify multilingual MSDS, batch test reports and production qualifications. All documents, factory and batch information must match one-to-one. Products with out-of-spec indicators or missing documents will be detained or returned at customs. All items must be checked before purchasing.

(II) Matching Downstream Production Processes and Equipment

NAD normally appears as white to off-white crystalline powder, soluble in water and slightly soluble in ethanol. It is suitable for powder blending, tableting, capsule filling, solid powder preparations, water-based cosmetic formulations, pharmaceutical synthesis and cell culture medium preparation. Key indicators impact production as follows:

1. β-isomer proportion: The biologically active component is the β configuration, while α-isomer is an ineffective impurity that directly determines biological activity. Strict control is mandatory for oral, pharmaceutical and high-end cosmetic applications.

2. Purity and related substances: Excessive impurities cause compatibility abnormalities, precipitation and increased irritation.

3. Moisture content, particle size and powder flowability: Affect automated tableting, capsule filling and powder packaging, preventing caking, material breakage and filling weight deviation.

4. Thermal and light stability: Prone to degradation and loss of activity under high-temperature granulation or transparent packaging environments; high-stability grades with light-shielding processes are preferred.

5. Solubility and solution stability: Oral liquids and water-based essences require rapid dissolution, clear solutions and no degradation/discoloration after long-term storage.

6. Compatibility: Compatible with nicotinamide, resveratrol and various vitamins. Small sample compatibility and stability tests are recommended for new formulations.

NAD is sensitive to light, high temperature, acid and alkaline environments and decomposes easily under harsh conditions. New customers must send small samples for process simulation testing in advance.

(III) Grade Selection by End-Product Positioning

· High-end anti-aging dietary supplements, pharmaceutical intermediates, cell culture reagents, professional cosmetic raw materials: Select high-purity refined grades with high β-isomer ratio, low residual solvents and low microbial counts.

· Ordinary functional powders and mass-market cosmetic raw materials: Standard food/cosmetic grades balancing quality and cost.

· General scientific research reagents and industrial synthetic raw materials: Basic reagent grades meeting fundamental reaction requirements.

· High-temperature production zones, transparent packaging and high-humidity storage areas: Prioritize stability-modified grades to extend finished product shelf life.

(IV) Supplier Production Capacity, Processes and Supply Stability Assessment

Mainstream processes: Biosynthesis or full chemical synthesis → separation and purification → isomer refinement → recrystallization → low-temperature drying. Core technical challenges include directional control of β-configuration, impurity removal, residual solvent management and anti-degradation treatment. Prefer large-scale biochemical manufacturers with full continuous production lines for biochemical synthesis/fermentation, multi-stage purification and isomer separation, as well as complete international compliance certifications such as GMP and ISO22000, HACCP. Formal large factories deliver consistent batch-to-batch performance in purity, β-isomer ratio and physicochemical indicators, with stable supply less affected by raw material shortages and environmental policies. Suppliers should support full-container, LCL and urgent small-batch direct shipments to major domestic ports. In-house laboratories must cover isomer analysis, content testing, solvent residue and full microbial testing, and cooperate with SGS, Eurofins for cross-border sampling inspections.

(V) Cross-Border Packaging, Storage and Transportation Planning

As fine biochemical crystalline powder, NAD is not classified as dangerous goods. Storage and transportation characteristics: slightly hygroscopic; highly sensitive to strong light, high temperature, acid and alkali, prone to decomposition, activity loss and yellow discoloration; prone to caking under pressure and odor absorption.

· Packaging: Standard food/reagent-grade PE inner film + double-layer light-proof and moisture-proof lining + sealed fiber drum (25kg per drum). High-purity reagent grades adopt vacuum aluminum foil independent inner bags with light-proof outer drums.

· Storage & transportation conditions: Full light-shielding, low-temperature, dry and odor-isolated environment; storage temperature ≤25℃, relative humidity ≤60%; temperature-controlled logistics preferred.

· Prohibitions: Do not ship with odorous, strong acid/alkali or oxidizing materials; limit stacking height to avoid compression caking; strictly follow first-in-first-out principle to shorten storage cycles and prevent degradation and activity loss during long-term storage.

(VI) Customization Services and Technical Support

Available services: purity grading, precise β-isomer specification control, particle size screening, powder stability modification, customized packaging specifications and multilingual label printing. Technical support includes compound formulation solutions, overseas regulatory interpretation, compliance document sorting and label specification guidance to meet target market requirements.

II. Universal Basic Full-Category Indicators (Mandatory Inspection for All Scenarios, Quality Bottom Line)

The following items are mandatory acceptance tests at factory release, upon arrival and customs clearance. Substandard indicators will lead to sharp efficacy decline, production failures and compliance risks and cannot be relaxed.

1. Total purity of β-nicotinamide adenine dinucleotide: General reagent/industrial grade ≥98.0%; standard food/cosmetic grade ≥99.0%; high-end pharmaceutical/cell culture grade ≥99.5%. Low purity means high by-product and impurity content, reduced activity, precipitation tendency and irritation risks.

2. β-isomer proportion (core activity indicator): ≥98.0% for high-end oral, pharmaceutical, cell culture and cosmetic applications, with strict limits on ineffective α-isomers. Excess isomers directly cause product failure.

3. Moisture content: General grade ≤0.50%; high-purity refined grade ≤0.30%. Excess moisture accelerates moisture absorption, caking and component degradation.

4. Ignition residue (ash content): General grade ≤0.10%; pharmaceutical/high-purity reagent grade ≤0.05%. Represents inorganic impurities; high values correlate with heavy metal risks.

5. Sensory properties: Qualified products are white to off-white crystalline powder with no peculiar odor. Yellowing, browning, discoloration or foreign odor indicates degradation or contamination; such batches are prohibited for oral, pharmaceutical and cosmetic use.

6. Solubility: Freely soluble in water at room temperature, forming a colorless, clear aqueous solution with no turbidity or precipitation. Poor solubility or turbid solutions indicate excessive impurities.

III. Special Control Indicators by Application Scenario (Differentiated Acceptance Standards)

(I) Pharmaceutical Intermediates & High-Purity Cell Culture Reagents (High-End Markets in Europe, US, Japan and South Korea)

Highest control level, aligned with USP/EP Pharmacopoeia and dedicated cell culture standards: Strict limits on α-isomers and various organic impurities; residual organic solvents and heavy metals meet the strictest limits for pharmaceutical/reagent grades; microbial count and endotoxin levels must pass standards; aqueous solution pH and long-term stability shall adapt to cell culture and pharmaceutical synthesis systems.

(II) High-End Anti-Aging Dietary Supplements (Mainstream Global Mid-to-High-End Markets)

Core requirements: Microbial indicators (total plate count, E. coli, mold, pathogenic bacteria) comply with cGMP and food hygiene standards; heavy metals follow special limits for dietary supplements; excellent powder flowability compatible with automated tableting and capsule equipment; components remain stable without degradation under high/low temperature and light exposure.

(III) High-End Anti-Aging Skincare & Serum Raw Materials (Global Cosmetic Market)

Key requirements: Low irritation and ultra-low impurity content; heavy metal and microbial indicators meet cosmetic raw material limits; aqueous solutions maintain long-term stability with no discoloration, precipitation or activity loss under light and conventional acid-base conditions.

(IV) Ordinary Functional Powders & General Cosmetic Raw Materials (Global General Market)

Acceptance focuses on total purity, moisture content, appearance and basic solubility, complying with local food/cosmetic standards while balancing cost performance.

(V) Industrial Synthetic Raw Materials & General Laboratory Reagents (Southeast Asia, Middle East, South America, Eastern Europe)

Moderately relaxed indicators; only total purity and appearance are verified to meet basic chemical reactions and routine experiments.

IV. Cross-Border Procurement Supporting Dimensions (Qualifications, Customization, Supply, Risk Reminders)

(I) Mandatory Qualification Documents for Global Markets

General basic documents: production qualification certificates, ISO22000, GMP, multilingual MSDS, batch-by-batch COA, full-item SGS test reports.

· EU: REACH registration, EP Pharmacopoeia reports, food/cosmetic compliance assessment documents.

· North America: FDA raw material filing, cGMP certificates, USP reports (pharmaceutical grade).

· Japan & South Korea: MHLW filing, special test reports for solvent residues, microorganisms and isomers. Bonus qualifications: Non-GMO certificates, process traceability documents. All certificates and reports must be within validity period with consistent factory and batch information.

(II) Available Customization Services

1. Purity & isomer customization: Gradient purity of 98%/99%/99.5% with precise β-isomer proportion control.

2. Particle size screening: Fine powder or standard crystalline particles as required.

3. Stability modification: Improved resistance to light, heat and degradation.

4. Custom packaging: Standard drums, vacuum inner bags, small-specification reagent packaging with printed multilingual foreign labels.

5. Pre-blended compound raw materials: Pre-mixed with nicotinamide and antioxidants at specified ratios to simplify downstream batching.

(III) Key Screening Points for Supply Stability

Prioritize large-scale biochemical manufacturers with mature isomer separation, purification and anti-degradation processes; stable β-isomer ratio, purity and stability are core thresholds. Standard full-container lead time: 7–12 days; urgent small orders are supported. Small workshops feature poor isomer control, easy degradation and excessive solvent residues, failing to meet requirements of high-end food, pharmaceutical and cell culture markets in Europe, US, Japan and South Korea.

(IV) Inherent Product Risks & Procurement Precautions

1. Highly photosensitive and thermosensitive substance: Full light-shielding and low-temperature storage/transportation mandatory; exposure to light or high temperature triggers rapid decomposition, sharp activity loss and yellow discoloration.

2. Slightly hygroscopic: Sealed moisture-proof packaging is essential for sea freight and high-humidity regions; moisture absorption accelerates degradation and caking.

3. α-isomer is the core quality risk: Batch-by-batch β-isomer testing is required for high-end applications.

4. Intolerance to strong acids and alkalis: Avoid direct compounding with strongly acidic or alkaline raw materials in formulations.

5. Limited storage cycle: Purchase in batches as needed to prevent activity loss from long-term storage.

6. Often compounded with nicotinamide, NR, NMN for synergistic effects; compatibility and stability tests are recommended for new formulations.

For more professional and in-depth analysis on NAD purchasing, please contact HiSiaddi customer service.